Virus czar: Vaccines should work against Omicron variant

Coronavirus czar Salman Zarka says vaccines likely work against the Omicron strain, though he notes that the emergence of the viral mutant presents a “complicated situation.”

“There’s uncertainty; we need to decide what is correct to do with the uncertainty; I think the cabinet made the right choices,” he says, according to Ynet.

He adds that “there’s no room for panic. The vaccine gives us good protection, especially against severe cases, and so it’s important to get vaccinated.”

Others have expressed less certainty regarding the vaccine’s efficacy against the variant.

“At least from a speculative point of view we have some optimism that the vaccine should still work against a new variant for serious disease, but really we need to wait several weeks to have that confirmed,” Prof. Andrew Pollard, the director of the Oxford Vaccine Group, which developed the AstraZeneca vaccine, tells BBC radio.

A number of pharmaceutical firms, including AstraZeneca, Moderna, Novavax and Pfizer, say they have plans in place to adapt their vaccines in light of the emergence of Omicron. Pfizer and its partner BioNTech say they expect to be able to tweak their vaccine in around 100 days.

The Associated Press contributed to this report.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.